
Tbrid-Plus Tablet
Marketer
Bonsai Pharma
Salt Composition
Isoniazid (150mg) + Pyrazinamide (500mg) + Rifampicin (225mg)
Overview Tbrid-Plus Tablet
Tbrid-Plus tablets combine medications to combat tuberculosis, hindering the growth of causative bacteria. This prescription drug must be taken precisely as directed by your physician. Optimal efficacy requires ingestion on an empty stomach at consistent times. Exceeding the prescribed dosage can be harmful. Missed doses should be taken immediately upon recall. Complete the entire treatment course, even with symptom improvement; premature cessation may reduce effectiveness. Therapeutic effects might take time to manifest. Report worsening symptoms or lack of improvement to your doctor. Common side effects include nausea, vomiting, fever, dark urine, sweating, hypersalivation, etc. Hydration is crucial to manage side effects; escalating side effects require immediate medical attention. Severe adverse reactions are uncommon. Seek immediate medical assistance for allergic reactions (rashes, itching, swelling, breathing difficulties). Inform your doctor of all current medications before starting Tbrid-Plus. Patients with liver or kidney disease should proceed with caution and under medical supervision. Pregnant or breastfeeding individuals require prior consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest and a nutritious diet are recommended for faster recovery. Your physician may order lab tests to monitor the medication's effects.
Uses of Tbrid-Plus Tablet
Mycobacterium tuberculosis infection
Major Benefits of Tbrid-Plus Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Tbrid-Plus on an empty stomach. Refrain from consuming Tbrid-Plus with foods high in tyramine, including aged cheeses, cured meats, smoked fish, and certain beers.
Common Side effects of Tbrid-Plus Tablet:
- Nausea
- Vomiting
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Abdominal pain
- Skin rash
- Hepatitis (viral infection of liver)
- Lethargy
- Low blood platelets
- Thrombocytopenic purpura
- Cutaneous reactions
How to use Tbrid-Plus Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Tbrid-Plus Tablet on an empty stomach. Refrain from consuming Tbrid-Plus Tablet with foods high in tyramine, including but not limited to cheese, cured meats, smoked fish, and certain beers.
How Tbrid-Plus Tablet works:
Tbrid-Plus tablets combine isoniazid, pyrazinamide, and rifampicin to combat tuberculosis. Isoniazid hinders the TB bacteria's protective shell formation, whereas rifampicin disables a crucial bacterial enzyme (RNA polymerase), halting protein synthesis and reproduction. This combined action eradicates the infection by killing the bacteria. Pyrazinamide contributes by inhibiting bacterial growth.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Tbrid-Plus Tablet treatment can trigger adverse reactions including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like response).
PregnancyCONSULT YOUR DOCTOR
The use of Tbrid-Plus Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Tbrid-Plus Tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Tbrid-Plus Tablet side effects. These may include dizziness, fainting, visual disturbances, or other effects impacting driving safety.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Tbrid-Plus Tablets, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Tbrid-Plus Tablets. Dosage modification may be necessary. Physician consultation is recommended. Routine monitoring of liver function is advisable pre- and post-treatment initiation.
What if you forget to take Tbrid-Plus Tablet :
Should you forget a Tbrid-Plus Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tbrid-Plus Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Agents against infection |
